Title for MeetingAbstracts
Alphabetical listing of titles
-
A randomized, comparative trial of ZDV versus ZDV plus ddI versus ZDV plus ddC in persons with CD4 cell counts of less than 200/mm3.
-
A randomized, controlled clinical trial (Racing-Trial) comparing two treatment strategies.
-
A randomized, controlled clinical trial of the effect of Haemophilus influenzae type b (Hib) vaccine on pneumonia and meningitis in children living on Lombok Island, Indonesia.
-
A Randomized, Controlled Clinical Trial on Meropenem versus Imipenem/Cilastatin for the Treatment of Bacterial Infections.
-
A Randomized, controlled pilot study of HAART versus HAART plus IL-2 for the treatment of recently acquired HIV infection.
-
A randomized, controlled study of immediate vs deferred ganciclovir therapy in AIDS patients with cytomegalovirus peripheral retinitis.
-
A randomized, controlled study of immunogenicity of rgp160 vaccine in HIV-infected subjects.
-
A randomized, controlled study of the safety and efficacy of intravenous cidofovir (CDV, HPMPC) for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.
-
A Randomized, Controlled Trial Comparing Ganciclovir or Ganciclovir Plus Foscarnet (each at half dose) for Pre-Emptive Therapy of Cytomegalovirus Infection in Transplant Recipients.
-
A randomized, controlled trial of intermittent versus continuous highly active antiretroviral therapy (HAART).
-
A Randomized, Controlled Trial of Long Cycle Structured Intermittent Versus Continuous ARV Therapy for Chronic HIV Infection.
-
A randomized, controlled trial of male circumcision (MC) to prevent HIV infection in Kisumu, Kenya.
-
A Randomized, Controlled Trial of PEG-Interferon-alfa-2a plus Ribavirin vs Interferon-alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-co-infected Persons: Follow-up Results of ACTG A5071.
-
A Randomized, Controlled Trial of Pegylated Interferon alpha-2a with Ribavirin vs. Interferon alpha-2a with Ribavirin for the Treatment of Chronic HCV in HIV Co-Infection: ACTG A5071.
-
A randomized, controlled trial to evaluate a psychosocial intervention to improve quality of life in HIV infection.
-
A randomized, controlled, open-label study comparing the adherence and convenience of continuing Indinavir Q8H vs Switching to norvir/indinavir 400 mg/400 mg BID (The NICE Study).
-
A randomized, double blind placebo-controlled phase II trial of growth hormone and insulin-like growth factor I for AIDS wasting.
-
A Randomized, Double Blind Study of Three Days of Azithromycin Compared with Amoxicillin/Clavulante for the Treatment of Acute Otitis Media (AOM).
-
A Randomized, Double-Blind Study of Azithromycin (AZ) vs. Clarithromycin (CL) in Combination with Ethambutol for the Treatment of Disseminated Mycobacterium avium Complex (DMAC) Infection in AIDS Patients.
-
A Randomized, Double-Blind Study of Ertapenem (ETP) vs. Ceftriaxone (CTX) in Complicated Urinary Tract Infections (CUTI).
-
A randomized, double-blind study of the efficacy and safety of oral ganciclovir for the prevention of cytomegalovirus disease in HIV-infected person.
-
A Randomized, Double-blind Trial Assessing the Efficacy of Single-dose Perinatal Nevirapine Added to a Standard Zidovudine Regimen for the Prevention of Mother-to-child Transmission of HIV-1 In Thailand.
-
A Randomized, Double-Blind, Controlled Study of Cefoperazone/Sulbactam plus Co-trimoxazole Vs. Ceftazidime plus Co-trimoxazole in the Treatment of Severe Melioidosis.
-
A randomized, double-blind, dose-ranging phase II European study of the safety and efficacy of chronically administered butanoyl-castanospermine (MDL 28,574A) HIV-infected patients.
-
A Randomized, Double-Blind, Double-Dummy, Active-Comparator Controlled Multi-Center Study of the Efficacy and Safety of Valganciclovir vs Oral Ganciclovir for Prevention of CMV Disease in 372 High-Risk (D+/R-) Heart, Liver and Kidney Recipients.
-
A Randomized, Double-blind, Multicenter Comparison of Emtricitabine QD to Stavudine BID.
-
A Randomized, Double-Blind, Multicenter Study of 5 Day and 10 Day Therapy with Oral Bms-284756 in the Treatment of Acute Exacerbation of Chronic Bronchitis (AECB).
-
A Randomized, Double-Blind, Multicenter Study of a Novel Prodrug, Ceftizoxime-Alapivoxil (CZX-AP), in Compared to Cefpodoxime-Proxetil (CPDX-PR), in the Treatment of Acute Exacerbation of Chronic Bronchitis (AECB) and Bacterial Pnemonia (BP).
-
A Randomized, Double-blind, Multicenter Trial of Caspofungin (CAS) v Liposomal Amphotericin B (LAMB) for Empirical Antifungal Therapy (EAFRx) of Persistently Febrile Neutropenic (PFN) Patients (Pt).
-
A Randomized, Double-Blind, Multicenter, Comparative Study of Gatifloxacin (GAT) 400 mg IV and PO versus Ceftriaxone +/- Erythromycin (CTX+/-ERY) in Treatment of Community-Acquired Pneumonia (CAP) Requiring Hospitalization.